PubRank

Kazutaka Ikeda

Author PubWeight™ 111.35‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 MassBank: a public repository for sharing mass spectral data for life sciences. J Mass Spectrom 2010 6.16
2 Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology 2004 1.41
3 A rotarod test for evaluation of motor skill learning. J Neurosci Methods 2010 1.26
4 Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis. J Biol Chem 2008 1.19
5 Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype. Pharmacogenomics 2008 1.19
6 G protein-activated inwardly rectifying potassium channels as potential therapeutic targets. Curr Pharm Des 2006 1.19
7 Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex. Nat Commun 2012 1.16
8 Mitochondrial dysfunction and increased reactive oxygen species impair insulin secretion in sphingomyelin synthase 1-null mice. J Biol Chem 2010 1.16
9 Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice. Neuropsychopharmacology 2004 1.15
10 Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery. Pain 2009 1.11
11 A congenital muscular dystrophy with mitochondrial structural abnormalities caused by defective de novo phosphatidylcholine biosynthesis. Am J Hum Genet 2011 1.11
12 Mu opioid receptor-dependent and independent components in effects of tramadol. Neuropharmacology 2006 1.09
13 Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators. J Exp Med 2013 1.08
14 Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis. Nat Immunol 2013 1.06
15 Group III secreted phospholipase A2 regulates epididymal sperm maturation and fertility in mice. J Clin Invest 2010 1.06
16 Transgenic mice in the study of drug addiction and the effects of psychostimulant drugs. Ann N Y Acad Sci 2010 1.04
17 Inhibition of G protein-activated inwardly rectifying K+ channels by various antidepressant drugs. Neuropsychopharmacology 2004 1.01
18 Pharmacogenomics of the human µ-opioid receptor. Pharmacogenomics 2011 1.01
19 Association between KCNJ6 (GIRK2) gene polymorphisms and postoperative analgesic requirements after major abdominal surgery. PLoS One 2009 1.00
20 Active behaviours produced by antidepressants and opioids in the mouse tail suspension test. Int J Neuropsychopharmacol 2012 0.99
21 Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac). Br J Pharmacol 2003 0.98
22 Association of mu-opioid receptor gene polymorphism A118G with alcohol dependence in a Japanese population. Neuropsychobiology 2006 0.97
23 Functional lacrimal gland regeneration by transplantation of a bioengineered organ germ. Nat Commun 2013 0.97
24 Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer's disease. Lipids Health Dis 2013 0.97
25 Self-enhancement of hepatitis C virus replication by promotion of specific sphingolipid biosynthesis. PLoS Pathog 2012 0.96
26 Global metabolomic analysis of heart tissue in a hamster model for dilated cardiomyopathy. J Mol Cell Cardiol 2013 0.95
27 Reliability and validity of the Japanese version of the Addiction Severity Index (ASI-J). Nihon Arukoru Yakubutsu Igakkai Zasshi 2006 0.95
28 A new twist on behavioral genetics by incorporating wild-derived mouse strains. Exp Anim 2011 0.93
29 Inhibition of G protein-activated inwardly rectifying K+ channels by ifenprodil. Neuropsychopharmacology 2006 0.92
30 Reduced emotional and corticosterone responses to stress in mu-opioid receptor knockout mice. Neuropharmacology 2009 0.92
31 Gene polymorphisms of the mu opioid receptor in methamphetamine abusers. Ann N Y Acad Sci 2004 0.90
32 Inhibition of G protein-activated inwardly rectifying K+ channels by the antidepressant paroxetine. J Pharmacol Sci 2006 0.90
33 Methamphetamine-induced locomotor activity and sensitization in dopamine transporter and vesicular monoamine transporter 2 double mutant mice. Psychopharmacology (Berl) 2007 0.90
34 Reduced tumor growth in a mouse model of schizophrenia, lacking the dopamine transporter. Int J Cancer 2008 0.89
35 Study of association between alpha-synuclein gene polymorphism and methamphetamine psychosis/dependence. Ann N Y Acad Sci 2004 0.88
36 Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells. Int J Cancer 2013 0.88
37 Characterization of the 3' untranslated region of the human mu-opioid receptor (MOR-1) mRNA. Gene 2005 0.88
38 Food-reinforced operant behavior in dopamine transporter knockout mice: enhanced resistance to extinction. Ann N Y Acad Sci 2004 0.88
39 Modulators of G protein-activated inwardly rectifying K+ channels: potentially therapeutic agents for addictive drug users. Ann N Y Acad Sci 2004 0.88
40 Verification of the addiction severity index Japanese version (ASI-J) as a treatment-customization, prediction, and comparison tool for alcohol-dependent individuals. Int J Environ Res Public Health 2009 0.88
41 Functional characterization of an endogenous Xenopus oocyte adenosine receptor. Br J Pharmacol 2002 0.87
42 Intracisternal A-particle element in the 3' noncoding region of the mu-opioid receptor gene in CXBK mice: a new genetic mechanism underlying differences in opioid sensitivity. Pharmacogenet Genomics 2006 0.87
43 Overexpression of KLF15 transcription factor in adipocytes of mice results in down-regulation of SCD1 protein expression in adipocytes and consequent enhancement of glucose-induced insulin secretion. J Biol Chem 2011 0.87
44 Analysis of two major intracellular phospholipases A(2) (PLA(2)) in mast cells reveals crucial contribution of cytosolic PLA(2)α, not Ca(2+)-independent PLA(2)β, to lipid mobilization in proximal mast cells and distal fibroblasts. J Biol Chem 2011 0.87
45 Functional analysis of deep intronic SNP rs13438494 in intron 24 of PCLO gene. PLoS One 2013 0.87
46 Fluoxetine as a potential pharmacotherapy for methamphetamine dependence: studies in mice. Ann N Y Acad Sci 2006 0.87
47 Monoamine transporter as a target molecule for psychostimulants. Int Rev Neurobiol 2009 0.86
48 Inhibition of ATP citrate lyase induces an anticancer effect via reactive oxygen species: AMPK as a predictive biomarker for therapeutic impact. Am J Pathol 2013 0.86
49 Essential role of NMDA receptor channel ε4 subunit (GluN2D) in the effects of phencyclidine, but not methamphetamine. PLoS One 2010 0.86
50 Diversity of opioid requirements for postoperative pain control following oral surgery--is it affected by polymorphism of the μ-opioid receptor? Anesth Prog 2010 0.86
51 Quality control of fungus-specific glucosylceramide in Cryptococcus neoformans by endoglycoceramidase-related protein 1 (EGCrP1). J Biol Chem 2011 0.86
52 GM1 / GD1b / GA1 synthase expression results in the reduced cancer phenotypes with modulation of composition and raft-localization of gangliosides in a melanoma cell line. Cancer Sci 2010 0.86
53 True boundary for the formation of homoleptic transition-metal hydride complexes. Angew Chem Int Ed Engl 2015 0.85
54 Lipid polarity is maintained in absence of tight junctions. J Biol Chem 2012 0.85
55 Inhibitory effects of the antiepileptic drug ethosuximide on G protein-activated inwardly rectifying K+ channels. Neuropharmacology 2008 0.84
56 Increased body weight in mice lacking mu-opioid receptors. Neuroreport 2006 0.84
57 Evidence that variation in the peripheral benzodiazepine receptor (PBR) gene influences susceptibility to panic disorder. Am J Med Genet B Neuropsychiatr Genet 2006 0.84
58 Differential effects of donepezil on methamphetamine and cocaine dependencies. Ann N Y Acad Sci 2006 0.84
59 Implication of dopaminergic projection from the ventral tegmental area to the anterior cingulate cortex in μ-opioid-induced place preference. Addict Biol 2010 0.84
60 Mitochondrial dysfunction and reduced prostaglandin synthesis in skeletal muscle of Group VIB Ca2+-independent phospholipase A2gamma-deficient mice. J Lipid Res 2010 0.84
61 Functional identification of ASCT1 neutral amino acid transporter as the predominant system for the uptake of L-serine in rat neurons in primary culture. Neurosci Res 2004 0.84
62 Defective lipid remodeling of GPI anchors in peroxisomal disorders, Zellweger syndrome, and rhizomelic chondrodysplasia punctata. J Lipid Res 2012 0.83
63 Association between genetic polymorphisms of the β1-adrenergic receptor and sensitivity to pain and fentanyl in patients undergoing painful cosmetic surgery. J Pharmacol Sci 2012 0.83
64 Association between KCNJ6 (GIRK2) gene polymorphism rs2835859 and post-operative analgesia, pain sensitivity, and nicotine dependence. J Pharmacol Sci 2014 0.83
65 Reduced supraspinal nociceptive responses and distinct gene expression profile in CXBH recombinant inbred mice. J Pain 2013 0.83
66 Family dysfunction differentially affects alcohol and methamphetamine dependence: a view from the Addiction Severity Index in Japan. Int J Environ Res Public Health 2011 0.83
67 Hair follicular expression and function of group X secreted phospholipase A2 in mouse skin. J Biol Chem 2011 0.83
68 Methamphetamine modulation of gene expression in the brain: analysis using customized cDNA microarray system with the mouse homologues of KIAA genes. Brain Res Mol Brain Res 2005 0.83
69 Inhibition by cocaine of G protein-activated inwardly rectifying K+ channels expressed in Xenopus oocytes. Toxicol In Vitro 2007 0.82
70 Candidate gene polymorphisms predicting individual sensitivity to opioids. Naunyn Schmiedebergs Arch Pharmacol 2007 0.82
71 Increased oxidative stress impairs adipose tissue function in sphingomyelin synthase 1 null mice. PLoS One 2013 0.82
72 Genetic polymorphisms and human sensitivity to opioid analgesics. Methods Mol Biol 2010 0.82
73 Inhibition of G protein-activated inwardly rectifying K+ channels by different classes of antidepressants. PLoS One 2011 0.82
74 Inhibitory effect of selective serotonin reuptake inhibitors on the vesicular monoamine transporter 2. Neurosci Lett 2009 0.82
75 Zebrafish and mouse alpha2,3-sialyltransferases responsible for synthesizing GM4 ganglioside. J Biol Chem 2009 0.82
76 Is there genetic polymorphism evidence for individual human sensitivity to opiates? Curr Pain Headache Rep 2007 0.81
77 Pregnenolone sulfate potentiates the inwardly rectifying K channel Kir2.3. PLoS One 2009 0.81
78 Association between 5-hydroxytryptamine 2A receptor gene polymorphism and postoperative analgesic requirements after major abdominal surgery. Neurosci Lett 2010 0.81
79 Development and validation of the Stimulant Relapse Risk Scale for drug abusers in Japan. Drug Alcohol Depend 2006 0.81
80 Association between the variable number of tandem repeat polymorphism in the third exon of the dopamine D4 receptor gene and sensitivity to analgesics and pain in patients undergoing painful cosmetic surgery. Neurosci Lett 2013 0.81
81 Genetic deletion of vesicular monoamine transporter-2 (VMAT2) reduces dopamine transporter activity in mesencephalic neurons in primary culture. Neurochem Int 2007 0.81
82 Antidepressant-like effect of venlafaxine is abolished in μ-opioid receptor-knockout mice. J Pharmacol Sci 2010 0.81
83 Association study on catechol-O-methyltransferase (COMT) Val158Met gene polymorphism and NEO-FFI. Psychiatry Res 2010 0.81
84 Association of morphine-induced antinociception with variations in the 5' flanking and 3' untranslated regions of the mu opioid receptor gene in 10 inbred mouse strains. Pharmacogenet Genomics 2008 0.80
85 G protein-activated inwardly rectifying K+ channel inhibition and rescue of weaver mouse motor functions by antidepressants. Neurosci Res 2005 0.80
86 Association between dopamine beta hydroxylase rs5320 polymorphism and smoking behaviour in elderly Japanese. J Hum Genet 2012 0.80
87 A possible genetic mechanism underlying individual and interstrain differences in opioid actions: focus on the mu opioid receptor gene. Ann N Y Acad Sci 2004 0.80
88 Physiological roles of group X-secreted phospholipase A2 in reproduction, gastrointestinal phospholipid digestion, and neuronal function. J Biol Chem 2011 0.80
89 Molecular species of phospholipids with very long chain fatty acids in skin fibroblasts of Zellweger syndrome. Lipids 2013 0.79
90 Association between genetic polymorphisms in Ca(v)2.3 (R-type) Ca2+ channels and fentanyl sensitivity in patients undergoing painful cosmetic surgery. PLoS One 2013 0.79
91 Repeated methamphetamine administration alters expression of the NMDA receptor channel epsilon2 subunit and kinesins in the mouse brain. Ann N Y Acad Sci 2006 0.79
92 ADORA2A polymorphism predisposes children to encephalopathy with febrile status epilepticus. Neurology 2013 0.79
93 Cholecystokinin (CCK) and the CCKA receptor gene polymorphism, and smoking behavior. Psychiatry Res 2005 0.79
94 Assessment of Japanese stimulant control law offenders using the Addiction Severity Index--Japanese version: comparison with patients in treatment settings. Int J Environ Res Public Health 2009 0.78
95 Genome-wide association study of sensory disturbances in the inferior alveolar nerve after bilateral sagittal split ramus osteotomy. Mol Pain 2013 0.78
96 Inhibition of G-protein-activated inwardly rectifying K+ channels by the selective norepinephrine reuptake inhibitors atomoxetine and reboxetine. Neuropsychopharmacology 2010 0.78
97 Application of the Relapse Risk Scale to alcohol-dependent individuals in Japan: comparison with stimulant abusers. Drug Alcohol Depend 2008 0.78
98 Attenuated methamphetamine-induced locomotor sensitization in serotonin transporter knockout mice is restored by serotonin 1B receptor antagonist treatment. Behav Pharmacol 2015 0.78
99 [Individual differences in analgesic effects of narcotics]. Nihon Shinkei Seishin Yakurigaku Zasshi 2008 0.78
100 Inhibitory role of inducible cAMP early repressor (ICER) in methamphetamine-induced locomotor sensitization. PLoS One 2011 0.78
101 The relationship between alcoholism and DBI gene polymorphism in Japanese--genotyping of the +529A/T in DBI gene polymorphism based on PCR. Nihon Arukoru Yakubutsu Igakkai Zasshi 2007 0.78
102 Involvement of the N-methyl-D-aspartate receptor GluN2D subunit in phencyclidine-induced motor impairment, gene expression, and increased Fos immunoreactivity. Mol Brain 2013 0.78
103 TLR4-MD-2 complex is negatively regulated by an endogenous ligand, globotetraosylceramide. Proc Natl Acad Sci U S A 2013 0.78
104 The γ-secretase inhibitor DAPT increases the levels of gangliosides at neuritic terminals of differentiating PC12 cells. Neurosci Lett 2012 0.78
105 (-)-Pentazocine induces visceral chemical antinociception, but not thermal, mechanical, or somatic chemical antinociception, in μ-opioid receptor knockout mice. Mol Pain 2011 0.78
106 Combination of cell culture assays and knockout mouse analyses for the study of opioid partial agonism. Methods Mol Biol 2010 0.78
107 Monoamine transporter as a target molecule for psychostimulants. Nihon Yakurigaku Zasshi 2007 0.77
108 The association between personality, pain threshold and a single nucleotide polymorphism (rs3813034) in the 3'-untranslated region of the serotonin transporter gene (SLC6A4). J Clin Neurosci 2010 0.77
109 Exclusive expression of VMAT2 in noradrenergic neurons increases viability of homozygous VMAT2 knockout mice. Biochem Biophys Res Commun 2013 0.77
110 Quantitative Detection of µ Opioid Receptor: Western Blot Analyses Using µ Opioid Receptor Knockout Mice. Curr Neuropharmacol 2011 0.77
111 Reduced locomotor sensitization induced by methamphetamine and altered gene expression in ICER overexpressing mice. Nihon Shinkei Seishin Yakurigaku Zasshi 2011 0.77
112 Determination and physiological roles of the glycosylphosphatidylinositol lipid remodelling pathway in yeast. Mol Microbiol 2013 0.77
113 Characterization of a novel lipolytic enzyme from Aspergillus oryzae. Appl Microbiol Biotechnol 2012 0.77
114 Abolished thermal and mechanical antinociception but retained visceral chemical antinociception induced by butorphanol in mu-opioid receptor knockout mice. Neuropharmacology 2008 0.76
115 Influence of GIRK channel inhibition on relapse risk in Japanese alcohol-dependent inpatients. Nihon Shinkei Seishin Yakurigaku Zasshi 2012 0.76
116 Receptor knock-out and gene targeting. Generation of knock-out mice. Methods Mol Med 2003 0.76
117 Degeneration of pontine mossy fibres during cerebellar development in weaver mutant mice. Eur J Neurosci 2002 0.76
118 [Postoperative pain management following orthognathic surgery in consideration of individual differences--is the antinociceptive effect of fentanyl related to the genotype involving nucleotide at OPRM1?]. Masui 2009 0.76
119 Association analysis of delta-opioid receptor gene polymorphisms in methamphetamine dependence/psychosis. Am J Med Genet B Neuropsychiatr Genet 2006 0.76
120 Haplotype analysis of GSK-3β gene polymorphisms in bipolar disorder lithium responders and nonresponders. Clin Neuropharmacol 2014 0.76
121 Inhibition of g protein-activated inwardly rectifying k channels by phencyclidine. Curr Neuropharmacol 2011 0.75
122 Specific regions display altered grey matter volume in μ-opioid receptor knockout mice: MRI voxel-based morphometry. Br J Pharmacol 2014 0.75
123 Stress sensitivity in patients with atopic dermatitis in relation to the translocator protein 18 kDa (TSPO). J Nippon Med Sch 2014 0.75
124 [Drug dependence and methylphenidate]. Seishin Shinkeigaku Zasshi 2008 0.75
125 [Genetic polymorphisms and human sensitivity to pain and opioids]. Masui 2009 0.75
126 [Genetic polymorphisms commonly associated with sensitivity to various addictive substances]. Nihon Shinkei Seishin Yakurigaku Zasshi 2013 0.75
127 [Distinct mechanisms underlying pleasure and analgesia]. Nihon Yakurigaku Zasshi 2005 0.75
128 An anti CuO2-type metal hydride square net structure in Ln2M2As2H(x) (Ln=La or Sm, M=Ti, V, Cr, or Mn). Angew Chem Int Ed Engl 2014 0.75
129 [Genome-wide association study identified susceptibility loci associated with nicotine dependence in a Japanese population]. Nihon Shinkei Seishin Yakurigaku Zasshi 2013 0.75
130 JSNP Excellent Presentation Award for CINP2014: reduced supraspinal nociceptive responses and distinct gene expression profile in CXBH recombinant inbred mice. Nihon Shinkei Seishin Yakurigaku Zasshi 2015 0.75
131 Influence of GIRK channel inhibition on alcohol abstinence and relapse risk in Japanese alcohol-dependent outpatients. Nihon Shinkei Seishin Yakurigaku Zasshi 2011 0.75
132 [Pathology and treatment of autism spectrum disorders]. Nihon Yakurigaku Zasshi 2015 0.75
133 Vibrational properties of CaAlH5 and α-AlH3 with different AlH6 networks studied by inelastic neutron scattering. Inorg Chem 2011 0.75
134 [Association between lithium sensitivity and GSK3beta gene polymorphisms in bipolar disorder]. Nihon Shinkei Seishin Yakurigaku Zasshi 2012 0.75
135 [Side effects of opioid and gene variants]. Masui 2009 0.75
136 [The relationship between BDNF gene polymorphisms and alcoholics in Japan]. Nihon Arukoru Yakubutsu Igakkai Zasshi 2013 0.75
137 [Gene polymorphisms in ATP (purinergic) receptors and pain sensitivity]. Masui 2009 0.75
138 [Association between GSK3β polymorphisms and the smoking habits in young Japanese]. Nihon Shinkei Seishin Yakurigaku Zasshi 2015 0.75
139 [Genetic polymorphisms commonly influencing efficacy of diverse addictive substances]. Nihon Arukoru Yakubutsu Igakkai Zasshi 2014 0.75
140 New LaMAsH(x) (M = Co, Ni, or Cu) arsenides with covalent M-H chains. J Am Chem Soc 2014 0.75
141 [Relationship between GSK-3 beta -50T/C and DBI +529A/T polymorphisms in Japanese alcoholics]. Nihon Arukoru Yakubutsu Igakkai Zasshi 2010 0.75
142 [Relationship between Oprm1 polymorphism and morphine sensitivity in inbred-strain mice derived from wild mice]. Nihon Shinkei Seishin Yakurigaku Zasshi 2011 0.75
143 [The association between beta-adrenergic receptor gene polymorphisms and personality traits]. Nihon Shinkei Seishin Yakurigaku Zasshi 2012 0.75
144 [Serotonin receptor gene polymorphism and analgesic sensitivity]. Masui 2009 0.75
145 Identification of the sex pheromone components secreted by female moths of Peridroma saucia (Noctuidae: Noctuinae). Biosci Biotechnol Biochem 2002 0.75
146 [Haplotype analysis of serotonin 2A receptor gene polymorphisms and smoking behavior]. Nihon Shinkei Seishin Yakurigaku Zasshi 2013 0.75
147 [Substance related disorders and addictive disorders]. Seishin Shinkeigaku Zasshi 2014 0.75
148 [Association between norepinephrine transporter gene polymorphism and alcohol dependence in Japanese]. Nihon Arukoru Yakubutsu Igakkai Zasshi 2014 0.75
149 A novel SNP detection technique utilizing a multiple primer extension (MPEX) on a phospholipid polymer-coated surface. Mol Biosyst 2007 0.75
150 [Haplotype analysis of GSK-3beta gene polymorphisms and smoking behavior]. Nihon Shinkei Seishin Yakurigaku Zasshi 2013 0.75
151 Effects of interferon-alpha on cloned opioid receptors expressed in Xenopus oocytes. Life Sci 2004 0.75
152 [Influence of GIRK channel inhibition on relapse in Japanese alcohol-dependent inpatients]. Nihon Shinkei Seishin Yakurigaku Zasshi 2013 0.75